Laser Treatment of Tattoos With Pico Laser
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 85 |
Updated: | 7/11/2015 |
Start Date: | October 2013 |
Contact: | Shlomit Mann |
Email: | Shlomit.Mann@syneron.com |
Phone: | 972-73-244-2200 |
LASER TREATMENT OF TATTOOS WITH A DUAL WAVELENGTH PICOSECOND LASER
The purpose of this study is to determine whether Pico laser is effective and safe in the
treatment of unwanted tattoos.
treatment of unwanted tattoos.
The Investigational device is a dual wavelength laser system developed for treatment of
pigmented lesions and for tattoo removal. The base unit is a GentleMax Pro laser system
modified to emit light at wavelengths of 532 and 1064 nm and deliver pulse energy up to
400mJ, and pulse duration of 700 ps.
A multicenter study.
pigmented lesions and for tattoo removal. The base unit is a GentleMax Pro laser system
modified to emit light at wavelengths of 532 and 1064 nm and deliver pulse energy up to
400mJ, and pulse duration of 700 ps.
A multicenter study.
Inclusion Criteria:
1. Has Fitzpatrick skin type I-IV
2. Has unwanted non-cosmetic tattoo(s) and wishes to undergo laser treatments to remove
them
3. Is willing to consent to participate in the study
4. Is willing to comply with all requirements of the study including being photographed,
following post treatment care and attending all treatment and follow up visits
Exclusion Criteria:
1. Is hypersensitive to light exposure
2. Has an active sun tan
3. Has Fitzpatrick skin type V or VI
4. Has active localized or systemic infection
5. Is taking medication(s) for which sunlight is a contraindication
6. Has a history of squamous cell carcinoma or melanoma
7. Has a history of keloid scarring
8. Has used oral isotretinoin (Accutane®) within 12 months of initial treatment or plans
on using during the course of the study. Note: Skin must regain its normal degree of
moisture prior to treatment.
9. Has a history of immunosuppression/immune deficiency disorders (including HIV
infection or AIDS) or use of immunosuppressive medications
10. Is female and pregnant, has been pregnant within the last 3 months, is currently
breast feeding or planning a pregnancy during the study period
11. Is allergic to lidocaine, tetracaine or Xylocaine with epinephrine
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials